Denise Burns Legros
Corneal and Contact Management · Melbourne, FLNPI 1730297185
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,746 of the $5,731 with a category attached, or 82.8%. It is spread thinly across 19 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,197 and has fallen 91.0% since, to $198 in 2025.
Across 106 payments — averaging $54.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$865
- Johnson & Johnson Vision Care, Inc.$818
- Visionary Optics LLC$810
- AbbVie$809
- Coopervision Inc.$740
- Bausch & Lomb, A Division Of Bausch Health US, LLC$387
- plus $1K from 13 others
What the payments were for
- Consulting fees$1753%
- Food & beverage$4,74683%
- Gifts$81014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 30 | $865 |
| Johnson & Johnson Vision Care, Inc. | 30 | $818 |
| Visionary Optics LLC | 2 | $810 |
| AbbVie | 9 | $809 |
| Coopervision Inc. | 16 | $740 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $387 |
| Dompe US, Inc. | 2 | $184 |
| Sight Sciences, Inc. | 1 | $143 |
| Amgen | 1 | $125 |
| Bausch & Lomb Americas Inc. | 1 | $124 |
| Sun Pharmaceutical Industries Inc. | 1 | $122 |
| Aerie Pharmaceuticals, Inc. | 1 | $113 |
| Oyster Point Pharma, Inc. | 2 | $98 |
| Novartis | 1 | $98 |
| Glaukos Corporation | 1 | $94 |
| Lombart Brothers, Inc. | 1 | $69 |
| Synergeyes, Inc. | 1 | $60 |
| Lumibird Medical Inc. | 1 | $54 |
| Shire North American Group Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,731 in reported general payments places this provider in the 85th percentile of 67 corneal and contact management providers in Florida.
See all corneal and contact management providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 19 | $15,097 |
| LumiganBimatoprost | 17 | $11,295 |
| Latanoprost | 157 | $2,528 |
| Brimonidine Tartrate | 23 | $591 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 15 | $549 |
| Timolol Maleate | 34 | $403 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $809 | $26,39236 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 67 corneal and contact management providers in Florida.
Other corneal and contact management in Melbourne
- Roxanne Achong-CoanOcoee$171K
- Cory CollierBradenton$35K
- Justine SiergeyOrlando$21K
- Tamara MauleBoca Raton$12K
- Kenneth MallerOakland Park$12K
- Terry van der HeydenNaples$8K
- Brian ArmitageJacksonville$8K
- Gordon PennViera$7K
- Jose ArnaoGainesville$5K
- Eric RadzwillFort Lauderdale$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.